美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Novo Nordisk A/S B Shares ADRhedged

21.57

-3.8704-15.21%

成交量：1.14万

成交额：24.64万

市值：345.11万

市盈率：- -

高：22.10

开：22.10

低：21.49

收：25.44

52周最高：54.13

52周最低：21.49

股本：16.00万

流通股本：6.00万

量比：4.11

换手率：18.94%

股息：0.65

股息率：3.03%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

分析师：诺和诺德CagriSema受挫，或使投资者焦点转向并购战略

环球市场播报

大跌10%！诺和诺德CagriSema头对头替尔泊肽3期临床失败

生物药大时代

美股开盘，道指跌 0.33%，诺和诺德大跌 15.65%

诺和诺德股价重挫15.50% 市值跌276.18亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/NVOH"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":21.5696,"timestamp":1771870138922,"preClose":25.44,"halted":0,"volume":11361,"delay":0,"changeRate":-0.15213836477987422,"floatShares":60000,"shares":160000,"eps":0,"marketStatus":"交易中","change":-3.8704,"latestTime":"02-23 13:12:31 EST","open":22.1,"high":22.1,"low":21.49,"amount":246386.65457699998,"amplitude":0.023978,"askPrice":21.54,"askSize":100,"bidPrice":21.5,"bidSize":100,"shortable":0,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771880400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":25.44,"dividendRate":0.030293,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":20.69,"preClose":25.44,"latestTime":"09:24 EST","volume":150,"amount":3219.43995,"timestamp":1771856683498,"change":-4.75,"changeRate":-0.186714,"amplitude":0.205189},"postHourTrading":{"tag":"盘后","latestPrice":25.44,"preClose":25.44,"latestTime":"16:10 EST","volume":6,"amount":152.64,"timestamp":1771621804254,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":4.11469},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":60000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.11469,"shares":160000,"dividePrice":0.6534,"high":22.1,"amplitude":0.023978,"preClose":25.44,"low":21.49,"week52Low":21.49,"pbRate":"--","week52High":54.13,"institutionHeld":0,"latestPrice":21.5696,"eps":0,"divideRate":0.030293,"volume":11361,"delay":0,"ttmEps":0,"open":22.1,"prevYearClose":27.4362,"prevWeekClose":25.44,"prevMonthClose":31.55,"prevQuarterClose":27.4362,"fiveDayClose":26.325,"twentyDayClose":33.1797,"sixtyDayClose":25.1157},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613735996","title":"分析师：诺和诺德CagriSema受挫，或使投资者焦点转向并购战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2613735996","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613735996?lang=zh_cn&edition=fundamental","pubTime":"2026-02-24 00:36","pubTimestamp":1771864560,"startTime":"0","endTime":"0","summary":"诺和诺德的新一代减肥药 CagriSema 在头对头临床试验中，效果不及礼来的 Zepbound。这对这家丹麦药企试图重夺减肥药市场领先地位的努力构成新一轮打击。　　“我们实在找不到任何理由，在 CagriSema 获批上市后，医生会给患者开这款药而不是礼来的替尔泊肽。”　　“尽管我们仍认为 CagriSema 能够获批，但今日 RD4 试验结果意味着，面对疗效更好、耐受性更佳的竞品，其市场推广将举步维艰，诺和诺德除了价格外几乎没有其他竞争手段。”","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-24/doc-inhnvukz2596714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BKVL7J92.USD","LU0154236417.USD","BK4007","NVO","BK4532","BK4585","NVOX","IE00BZ1G4Q59.USD","NVOH","LU1093756168.USD","BK4588","LU1093756325.SGD","BK4599"],"gpt_icon":1},{"id":"2613801735","title":"大跌10%！诺和诺德CagriSema头对头替尔泊肽3期临床失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2613801735","media":"生物药大时代","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613801735?lang=zh_cn&edition=fundamental","pubTime":"2026-02-24 00:01","pubTimestamp":1771862504,"startTime":"0","endTime":"0","summary":"2月23日，诺和诺德宣布CagriSema对比替尔泊肽的减重III期REDEFINE 4研究未达到主要终点。受此消息影响，诺和诺德股价大跌15%。若按治疗方案评估，治疗84周后，CagriSema组和替尔泊肽组患者的体重分别减轻了20.2%和23.6%。本研究未能达到其主要终点，即在 84 周时证明 CagriSema 在体重下降方面相较于 tirzepatide 具有非劣效性。在本研究中，CagriSema 显示出良好的安全性和耐受性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224000516a7166405&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224000516a7166405&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","NVO","BK4599","LU0154236417.USD","LU1093756168.USD","BK4585","NVOX","LU1093756325.SGD","BK4007","BK4588","NVOH","BK4532","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2613638738","title":"美股开盘，道指跌 0.33%，诺和诺德大跌 15.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613638738","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613638738?lang=zh_cn&edition=fundamental","pubTime":"2026-02-23 22:35","pubTimestamp":1771857325,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7613820","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["TNA","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4599","NVOX","UDOW","BK4585","NVOH","UWM",".DJI","BK4535","BK4534","DOG","DIA","MNQmain","BK4007","BK4532","IE00BKVL7J92.USD","TWM","DDM","DXD","IWO","SRTY","TZA","LU0154236417.USD","SCHD","MYMmain","NVO","BK4550","BK4581","DJX","RWM","SDOW","BK4588","LU1093756325.SGD","IWN"],"gpt_icon":0},{"id":"2613802567","title":"诺和诺德股价重挫15.50% 市值跌276.18亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613802567","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613802567?lang=zh_cn&edition=fundamental","pubTime":"2026-02-23 22:31","pubTimestamp":1771857065,"startTime":"0","endTime":"0","summary":"北京时间2026年02月23日22时31分，诺和诺德股票出现异动，股价快速下跌15.50%。截至发稿，该股报40.07美元/股，成交量1906.35万股，换手率0.43%，振幅0.84%。最近的财报数据显示，该股实现营业收入467.36亿美元，净利润154.90亿美元，每股收益3.49美元，毛利375.48亿美元，市盈率11.06倍。诺和诺德股票所在的制药行业中，整体涨幅为1.81%。诺和诺德还拥有一个生物制药部门，专注于治疗血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223223105a716318a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223223105a716318a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK4585","NVOH","BK4532","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4007","IE00BKVL7J92.USD","NVOX","BK4599","LU1093756168.USD","LU0154236417.USD","BK4588"],"gpt_icon":1}],"pageSize":4,"totalPage":24,"pageCount":1,"totalSize":94,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NVOH\",params:#limit:6,delay:false,,,undefined,":[]}}